Page 49 - Read Online

Shephard et al. Role of exosomes in prostate cancer

Database Syst Rev 2006;(4):CD005247. microenvironment derived exosomes pleiotropically modulate cancer
119. Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms cell metabolism. Elife 2016;5:e10250.
associated with altered intracellular distribution of anticancer agents. 127. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
Pharmacol Ther 2000;85:217-29. 128. Vander Heiden MG, Cantley LC, Thompson CB. Understanding
120. Lopes-Rodrigues V, Seca H, Sousa D, Sousa E, Lima RT, Vasconcelos the Warburg effect: the metabolic requirements of cell proliferation.
MH. The network of P-glycoprotein and microRNAs interactions. Int Science 2009;324:1029-33.
J Cancer 2014;135:253-63. 129. Welton JL, Webber JP, Botos LA, Jones M, Clayton A. Ready-made
121. Corcoran C, Rani S, O’Brien K, O’Neill A, Prencipe M, Sheikh R, chromatography columns for extracellular vesicle isolation from
Webb G, McDermott R, Watson W, Crown J, O’Driscoll L. Docetaxel- plasma. J Extracell Vesicles 2015;4:27269.
resistance in prostate cancer: evaluating associated phenotypic 130. Duijvesz D, Versluis CY, van der Fels CA, Vredenbregt-van den
changes and potential for resistance transfer via exosomes. PloS One Berg MS, Leivo J, Peltola MT, Bangma CH, Pettersson KS, Jenster
2012;7:e50999. G. Immuno-based detection of extracellular vesicles in urine as
122. Zhang FF, Zhu YF, Zhao QN, Yang DT, Dong YP, Jiang L, Xing WX, diagnostic marker for prostate cancer. Int J Cancer 2015;137:2869-78.
Li XY, Xing H, Shi M, Chen Y, Bruce IC, Jin J, Ma X. Microvesicles 131. Wang J, De Veirman K, Faict S, Frassanito MA, Ribatti D, Vacca
mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 A, Menu E. Multiple myeloma exosomes establish a favourable
human ovarian cancer cells, conferring paclitaxel-resistance. Eur J bone marrow microenvironment with enhanced angiogenesis and
Pharmacol 2014;738:83-90. immunosuppression. J Pathol 2016;239:162-73.
123. Lopes-Rodrigues V, Di Luca A, Mleczko J, Meleady P, Henry M, 132. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A,
Pesic M, Cabrera D, van Liempd S, Lima RT, O’Connor R, Falcon-
Perez JM, Vasconcelos MH. Identification of the metabolic alterations Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII
associated with the multidrug resistant phenotype in cancer and their by microvesicles derived from tumour cells. Nat Cell Biol
intercellular transfer mediated by extracellular vesicles. Sci Rep 2008;10:619-24.
2017;7:44541. 133. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial
124. Altadill T, Campoy I, Lanau L, Gill K, Rigau M, Gil-Moreno A, expression of autocrine VEGF upon the uptake of tumor-derived
Reventos J, Byers S, Colas E, Cheema AK. Enabling metabolomics microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A
based biomarker discovery studies using molecular phenotyping of 2009;106:3794-9.
exosome-like vesicles. PloS One 2016;11:e0151339. 134. Taraboletti G, D’Ascenzo S, Giusti I, Marchetti D, Borsotti P,
125. Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang Millimaggi D, Giavazzi R, Pavan A, Dolo V. Bioavailability of VEGF
LJ, Romàn-Pèrez E, D’Arcy M, Freemerman AJ, Perou CM, Troester in tumor-shed vesicles depends on vesicle burst induced by acidic pH.
MA. Impact of tumor microenvironment and epithelial phenotypes on Neoplasia 2006;8:96-103.
metabolism in breast cancer. Clin Cancer Res 2013;19:571-85. 135. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro
126. Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini R, Kohn EC. Exosomes released by K562 chronic myeloid leukemia
JC, Tudawe T, Seviour EG, San Lucas FA, Alvarez H, Gupta S, cells promote angiogenesis in a Src-dependent fashion. Angiogenesis
Maiti SN, Cooper L, Peehl D, Ram PT, Maitra A, Nagrath D. Tumor 2012;15:33-45.

Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ December 6, 2017 301